Video: The CHOSOURCE™ expression platform for advanced bioproduction

Horizon's CHO-K1 GS knockout expression platform enables rapid identification of clones expressing high levels of recombinant therapeutic protein during development of a stable cell line. While our flexible licensing terms ensure this high-performance platform is easily accessible to meet the demands of cost-effective biomanufacturing.